ReNeuron collaborates with King's College

Guildford, UK-based ReNeuron has signed a research collaboration agreement with King's College London to further develop the company's c-mycER stem cell expansion technology. The research will be part-funded by the UK government under its Knowledge Transfer Partnership scheme.

Michael Antoniou, who heads the nuclear biology group in the Department of Medical and Molecular Genetics at King's, will develop new delivery constructs to enhance the efficiency and safety of the c-mycER transgene when used to grow stem cell lines.

John Sinden, chief scientific officer of ReNeuron, said: "we have already successfully scaled up our ReN001 cell line for stroke using our c-mycER platform. Having demonstrated that the technology works well in our lead therapeutic programme, we are looking to this collaboration to enhance efficiency when selecting and scaling future cell line products using c-mycER. We believe this will ultimately lead to shorter therapeutic development timelines for ReNeuron's stem cell therapies. The UK government's support for this collaboration through the KTP scheme will assist in ensuring that the program realises its aims in the shortest possible timeframe."